Pancreatic elastase-1 is one of the proteolitic enzymes produced by acinar pancreatic cells, secreted as zymogen proelastase into the duodenum, then activated by tripsin to become elastase. Elastase belongs to endopeptidase and plays a role in hydrolisis of internal peptide binding of polipeptide protein.
Pancreatic elastase-1 is one of the proteolitic enzymes produced by acinar pancreatic cells, secreted as zymogen proelastase into the duodenum, then activated by tripsin to become elastase. Elastase belongs to endopeptidase and plays a role in hydrolisis of internal peptide binding of polipeptide protein. 1, 2 On its way in small intestine, elastase is not broken-down and not hydrolized and still as a stable molecule in the lumen of gastrointestinal tract, so its concentration in the feces reflects pancreatic secretion. 3, 4, 5 Determining elastase-1 concentration in the feces is an indirect and non-invasive test of pancreatic function since it's easily done and not necessary to insert a pipe into duodenum. If concentration of 200 µg/gram feces is considered as a normal limit, sensitivity and specificity of elastase-1 concentration in feces using an enzyme-link immunosorbent assay are high, 6, 7, 8 both of them are 93% for patients with pancreatic insufficiency. 7 Studies of pancreatic elastase-1 concentration in infants showed that the concentration of more than 200 µg/gram feces as a normal level can be used for infants aged more than 2 weeks, regardless of gestational age, but can not be used for those aged less than 2 weeks. This maybe due to physiological immaturity factor. 9 Studies of pancreatic elastase-1 concentration in infant's feces is still rare. There have been some reports from European researchers, 8, 9, 10, 11, 12 but so far there has not been a report of elastase-1 concentration in feces in Indonesia, especially in infants.
The aim of this study is to know the concentration of elastase-1 in term and preterm infants aged 1 day to 120 days. This is a preliminary report of the study on the ontogeny of pancreatic elastase-1 in term and preterm infants.
METHODS
The examination of pancreatic elastase-1 concentration was done on 28 healthy preterm infants and 34 term infants who came to Budi Kemuliaan Maternity Hospital Jakarta, aged 1, 3, 7, 14, 30, 60, 90 and 120 days. Fecal specimen was taken and stored in a freezer in -20°C before analysis. Fecal elastase-1 was measured immunologically based on 2 monoclonal antibodies (ScheBo Tech, Wettenberg, Germany). 13, 14 Concentration less than 200 µg/gram feces is classified as pancreatic insuficiency.
7,10 Term infant is defined as an infant born in full 37 weeks to 42 weeks of gestational age, and preterm infant is born in less than 37 weeks of gestational age. Low birth weight infant is an infant with birth weight less than 2500 grams. 15, 16 Fecal elastase-1 concentrations of preterm and term infants were compared based on age groups. The data was analyzed using Mann-Whitney test. The increase of elastase-1 concentration on preterm infant from the first to 14 th day of life was also evaluated.
RESULTS
Fecal elastase-1 concentration of 28 preterm and 54 term infants who were born and came to Budi Kemuliaan Maternity Hospital from September 2000 to March 2001 had been measured. The preterm infants were in 30-36 weeks of gestational age (mean 34,5 weeks), and the term infants were in 38-40 weeks of gestational age (mean 39 weeks). Table 1 showed the elastase-1 concentration in infants aged 1-120 days. The elastase-1 concentration in infants aged 1-14 days still fluctuated below 200 µg/gram feces ( Figure 1) . The difference in value of elastase-1 concentration in preterm infant and term infant was not significant (Table 1) . There was a significant increase of elastase-1 concentration in preterm infant from the first day to the 14 th day of life (Table 2) . At the first day of life 80% of preterm and 60% of term infants had elastase-1 concentration less than 200 µg/gram feces and by the age of 7 days 50% preterm infants and 33% term infants had concentration less than 200 µg/gram feces. 
DISCUSSION
This study showed that pancreatic elastase-1 concentration in feces of infants aged less than 14 days still fluctuated below 200 µg/gram feces. This fluctuation of concentration were found in both preterm and term infants. In preterm infants, the elastase-1 concentration was lower than that of term infants, but the difference was not significant. After 14 days of life, the elastase-1 concentration rate was stable over 200 µg/gram feces. In 1995, Terbrack et al found that the elastase-1 concentration in meconium was 63,9 ± 3,6 µg/gram feces and by the age of 1 month was 586,1 ± 65,4 µg/gram feces. 10 After one month, the increase of the concentration was very small and not significant. 10, 11 Von Seebach et al found that at the age of 0-48 hours the elastase-1 concentration in feces in 43% of term infants had achieved adult concentration whereas in 100% of preterm infants it was still below 30 µg/gram feces. By the age of 1 week, 97,4% of term infants and 85% of preterm infants had achieved normal level of concentration and after the second week both of them were stable over 200 µg/gram feces. 12 Our study found that by the age of one day, 80% of preterm infants and 60% of term infants had concentration less than 200 µg/gram feces, while by the age of one week 50% of preterm infants and 33% of term infants still had concentration less than 200 µg/gram feces. Although the sample size of this study was small, the result was not different from the previous studies. In conclusion, this preliminary report corroborates other previous studies showed that the pancreatic elastase-1 concentration in feces in infants until the age of 14 days still fluctuated below 200 µg/gram feces and after 2 weeks it was stable over 200 µg/gram feces. Future study with larger representative sample size is needed to establish the development of pancreatic elastase-1 concentration in infants less than 14 days.
